Last reviewed · How we verify

NCT02629640

Enhanced CJD Surveillance in the Older Population

Completed Last updated 10 June 2024
What this trial tests

trial testing Medical history questionnaire in Prion Disease in 30 participants. Completed in 31 March 2022.

Timeline
19 January 2016
Primary endpoint
31 March 2022
31 March 2022

Quick facts

Lead sponsorUniversity of Edinburgh
StatusCompleted
Study typeOBSERVATIONAL
Enrollment30
Start date19 January 2016
Primary completion31 March 2022
Estimated completion31 March 2022
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

University of Edinburgh

Who can join

65 and older, any sex, with Prion Disease or Dementia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study to investigate if cases of Creutzfeldt-Jakob Disease (CJD) and other forms of prion disease are being missed in older adults living within Lothian.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of Edinburgh trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02629640.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing